Related content

A Complication-Free Course Ensures a Survival Advantage in Patients After Regional Therapy for Metastatic Colorectal Cancer

By Osborne Dana   Pappas Effie   Alexander Gerald   Boe Brian   Cantor Alan B   Rosemurgy Alexander   Zervos Emmanuel  

The American Surgeon, Vol. 72, Iss. 6, 2006-06 ,pp. : 505-510

Southeastern Surgical Congress

Access to resources Recommend Favorite

Multi-Modality Therapy for Metastatic Colorectal Cancer—Ready for Prime Time?

By Chua Terence C.   Marshall John L.   Marshall M. Blair   Esquivel Jesus  

The American Surgeon, Vol. 76, Iss. 7, 2010-07 ,pp. : 777-778

Southeastern Surgical Congress

Access to resources Recommend Favorite

Shifting to first-line regimen after previous failure of irinotecan and oxaliplatin containing chemotherapies in unresectable metastatic colorectal cancer: a retrospective study of case analysis

By Hsu Chao-Wen   King Tai-Ming   Lin Chieh-Hsin   Wang Hsin-Tai   Ou Wen-Chieh   Wang Jui-Ho  

International Journal of Colorectal Disease, Vol. 24, Iss. 4, 2009-04 ,pp. : 377-383

Springer Publishing Company

Access to resources Recommend Favorite

Systematic Review: Surgery for Patients with Metastatic Melanoma during Active Treatment with Ipilimumab

By Baker Justin J.   Stitzenberg Karyn B.   Collichio Frances A.   Meyers Michael O.   Ollila David W.  

The American Surgeon, Vol. 80, Iss. 8, 2014-08 ,pp. : 805-810

Southeastern Surgical Congress

Access to resources Recommend Favorite

Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review

By Eisenberger Andrew  

International Journal of Colorectal Disease, Vol. 23, Iss. 6, 2008-06 ,pp. : 559-568

Springer Publishing Company

Access to resources Recommend Favorite